Company: NCEL
Filing Date: 2025-03-03
Form Type: F-4/A
Source: 0001213900-25-018981
Chunk: 359

Company: NewcelX Ltd.
Filing Date: 2025-03-03
Form: F-4/A
Chunk 359
---
, 2025, and (ii) 72,500 Kadimastem Ordinary Shares issuable upon exercise of options vested and exercisable within 60 days of February 27, 2025. (4)Consists of: (i) 200 Kadimastem Ordinary Shares, and (ii) 2,500 Kadimastem Ordinary Shares issuable upon exercise of options vested and exercisable within 60 days of February 27, 2025. (5)Consists of 240 Kadimastem Ordinary Shares issuable upon exercise of options vested and exercisable within 60 days of February 27, 2025. (6)Consists of (i) 695,978 Kadimastem Ordinary Shares, and (ii) 692,892 Kadimastem Ordinary Shares issuable upon exercise of warrants exercisable within 60 days of February 27, 2025. Julien Ruggieri, the sole manager of League Jinn Sarl holds voting and dispositive power over the securities held by League Jinn Sarl. The address of League Jinn Sarl is 4 -6Rue Du Fort Rheinsheim, L -2419, Luxemburg.

202

(7)Consists of 538,670 Kadimastem Ordinary Shares. Ms. Adi Wolf has the voting and dispositive power over the shares held by Clover Wolf Capital Limited Partnership. The mailing address of Ms. Adi Wolf is 24 Bodenheimer, Tel Aviv 6200838, Israel. (8)Consists of (i) 459,906 Kadimastem Ordinary Shares, and (ii) 1,511,217 Kadimastem Ordinary Shares issuable upon exercise of warrants exercisable within 60 days of February 27, 2025. The warrants are subject to a beneficial ownership limitation of 9.99%, which such limitation restricts Alpha Capital Anstalt from exercising that portion of the warrants that would result in Alpha Capital Anstalt and its affiliates owning, after exercise, a number of Kadimastem Ordinary Shares in excess of the beneficial ownership limitation. As a result, the number of Common Shares reflected in the table owned by Alpha Capital Anstalt includes (a) any outstanding Kadimastem Ordinary Shares held by such shareholder, and (b) if any, the number of warrants exercisable into Kadimastem Ordinary Shares that the holder has the right to acquire within 60 days of February